Application of Derivative and Ratio Spectra Derivative Spectrophotometry for the Determination of Pseudoephedrine Hydrochloride and Acrivastine in Capsules

Abstract

Two new spectrophotometric methods are used for the determination of acrivastine and pseudoephedrine hydochloride in their mixture without previous chemical separation. In the first, second derivative spectrophotometry, the measurements are made at 288.0 nm for acrivastine and at 270.2 nm for pseudoephedrine hydrochloride in the second derivative spectra of their solution in 0.1M NaOH. In the second, ratio spectra derivative spectrophotometry, the amplitudes are measured at 276.0 nm and 298.5 nm corresponding to two maximums for acrivastine, and at 252.6 nm and 268.3 nm corresponding to a maximum and a minumum, respectively, for pseudoephedrine hydrochloride in first derivative of their ratio spectra plotted by using of their solutions as divisor. The methods were successfully applied for the determination of these drugs in a commercial pharmaceutical formulation capsule.     

Determination of Pantoprazole, Rabeprazole, Esomeprazole, Domperidone and Itopride in Pharmaceutical Products by Reversed Phase Liquid Chromatography Using Single Mobile Phase

A simple, sensitive, and precise high performance liquid chromatographic method for the analysis of pantoprazole, rabeprazole, esomeprazole, domperidone and itopride, with ultraviolet detection at 210 nm, has been developed, validated, and used for the determination of compounds in commercial pharmaceutical products. The compounds were well separated on a Hypersil BDS C18 reversed-phase column by use of a mobile phase consisting of 0.05 M, 4.70 pH, potassium dihydrogen phosphate buffer - acetonitrile (720:280 v/v) at a flow rate of 1.0 mL min^?1. The linearity ranges were 400–4,000 ng mL^?1 for pantoprazole, 200–2,000 ng mL^?1 for rabeprazole, 400–4,000 ng mL^?1 for esomeprazole, 300–3,000 ng mL^?1 for domperidone and 500–5,000 ng mL^?1 for itopride. Limits of detection (LOD) obtained were: pantoprazole 147.51 ng mL^?1, rabeprazole 65.65 ng mL^?1, esomeprazole 131.27 ng mL^?1, domperidone 98.33 ng mL^?1 and itopride 162.35 ng mL^?1. The study showed that reversed-phase liquid chromatography is sensitive and selective for the determination of pantoprazole, rabeprazole, esomeprazole, domperidone and itopride using single mobile phase.     

试剂固定化的流动注射化学发光测定盐酸伊托必利

基于盐酸伊托必利在碱性条件下对铁氰化钾鲁米诺化学发光体系有较强的抑制作用,并采用离子交换固定法将鲁米诺和铁氰化钾全部固定在阴离子交换树脂上,联用流动注射技术建立了测定盐酸伊托必利的新方法。本法的线性范围为1.0~100.0μg/mL,检出限0.2μg/mL,对20μg/mL的盐酸伊托必利11次平行测定,其相对标准偏差为2.1%。单次测定在45 s内完成。此固定化柱可使用200次以上。可用于盐酸伊托必利片剂中盐酸伊托必利的质量检测。     

Development and Validation of Derivative Spectrophotometric Method for Determination of Rabeprazole Sodium in Pharmaceutical Formulation

Abstract

The aim of this work is to develop and validate the derivative spectrophotometric method for determination of the proton pump inhibitor rabeprazole sodium in pharmaceutical formulations. The technique was applied using water (pH 10.0) as diluent. The first‐order derivative spectra were obtained at N=5, Δλ=4.0 nm, and determinations were made at 304 nm. The method showed high specificity in the presence of formulation excipients and good linearity in the concentration range of 6.0 to 18.0 µg/mL^?1. The intra‐ and interday precision data demonstrated the method has good reproducibility [Relative Standard Deviation ((RSD)=1.0 interdays)]. Accuracy was also evaluated and results were satisfactory (mean recovery of 99.15%). The detection and quantitation limits were 0.055 and 0.17 µg/mL^?1, respectively. The method was demonstrated to be adequate for routine analysis in quality control.     

Quantitative analysis of rabeprazole sodium in commercial dosage forms by spectrophotometry

The main aim of this work is to develop and validate two spectrophotometric methods for the quantitative analysis of rabeprazole sodium in commercial dosage forms. Method A is based on the reaction of drug with 3-methyl-2-benzothiazolinone hydrazone hydrochloride (MBTH) in the presence of ammonium cerium(IV) nitrate in acetic acid medium at room temperature to form red-brown product which absorbs maximally at 470 nm. Method B utilizes the reaction of rabeprazole sodium with 1-chloro-2,4-dinitrobenzene (CDNB) in dimethyl sulfoxide (DMSO) at 45+/-1 degrees C to form yellow colored Meisenheimer complex. The colored complex has a characteristic band peaking at 420 nm. Under the optimized reaction conditions, proposed methods are validated as per ICH guidelines. Beer's law is obeyed in the concentration ranges of 14-140 and 7.5-165 microg ml(-1) with linear regression equations of A=6.041 x 10(-4)+1.07 x 10(-2)C and A=1.020 x 10(-3)+5.0 x 10(-3)C for methods A and B, respectively. The limits of detection for methods A and B are 1.38 and 0.75 microg ml(-1), respectively. Both methods have been applied successfully for the estimation of rabeprazole sodium in commercial dosage forms. The results are compared with the reference UV spectrophotometric method.     

Simultaneous quantification of promazine hydrochloride and its sulfoxide in pharmaceutical preparations.

The use of derivative UV-spectrophotometry is proposed for the simultaneous quantification of promazine hydrochloride in the presence of sulfoxide, and vice versa. For this purpose, mathematical parameters were established for generating derivative spectra of analytes. The determination of promazine was made using the first-order derivative (deltalambda = 10 nm, second polynomial degree) at 268 nm. The quantification of sulfoxide was achieved by applying third-derivative spectra (deltalambda = 14 nm, sixth polynomial degree) based on measurements of the amplitude at 342 - 344 nm. An elaborated method was successfully used to determine analytes in commercial promazine pharmaceuticals. The obtained results agreed well with those obtained by the HPLC method.     

Rapid and accurate determination of chlorpheniramine maleate, noscapine hydrochloride and guaiphenesin in binary mixtures by derivative spectrophotometry

Rapid and accurate binary mixture resolution of chlorpheniramine maleate-noscapine hydrochloride and chlorpheniramine maleate-guaiphenesin, was performed. Derivative spectrophotometry, by the zero-crossing measurements, was used due to the drugs closely overlapping absorption spectra. Neither sample pretreatment nor separation were required. Linear calibration graphs of first derivative values at 268.0 and 261.0 nm for chlorpheniramine-maleate-noscapine hydrochloride and at 273.2 and 261.0 nm for chlorpheniramine-guaiphenesin were obtained vs. concentration with negligible intercept on the y-axis. Thus, the derivative spectrophotometry method was applied to the determination of these drugs in binary mixtures obtaining selectivity, accuracy and precision.     

An application of UV-derivative spectrophotometry and bivariate calibration algorithm for study of photostability of levomepromazine hydrochloride

Derivative spectrophotometry and bivariate calibration algorithm were used for study of run of photooxidation of levomepromazine hydrochloride (LV). The actual concentrations of LV and its main degradation product levomepromazine sulphoxide (LV-SO) were calculated using data provided by applied methods. The direct reading of absorbance values at 302 nm and 334 nm were employed for quantification of LV and LV-SO, respectively, in the case of bivariate method. The derivative spectrophotometric method is based on transformation of zero-order spectra into first derivative. The values of first derivative at 334 nm were used for quantification of LV while at 278 nm for assay of LV-SO. The obtained quantitative data were applied for investigation of kinetics of photodegradation of LV.     

A comparative study on various spectrometries with thin layer chromatography for simultaneous analysis of drotaverine and nifuroxazide in capsules

Three spectrophotometric methods including Vierordt's method, derivative, ratio spectra derivative, and thin layer chromatography (TLC)-UV densitometric method were developed for simultaneous determination of drotaverine HCl (DRT) and nifuroxazide (NIF) in presence of its impurity, 4-hydroxybenzohydrazide (4-HBH). In Vierordt's method, (E(1 cm)(1%)) values were calculated at 227 and 368 nm in the zero-order spectra of DRT and NIF. By derivative spectrophotometry, the zero-crossing method, drotaverine HCl was determined using the second derivative at 245 nm and the third derivative at 238 nm, while nifuroxazide was determined using the first derivative at 399 nm and the second derivative at 411 nm. The ratio spectra derivative spectrophotometry is basedon the measure of the amplitude at 459 nm for DRT and at 416 nm for NIF in the first derivative of the ratio spectra. Calibration graphs of the three spectrophotometric methods were plotted in the range 1-10 mug/ml of DRT and 2-20 mug/ml of NIF. TLC-UV densitometric method was achieved on silica gel plates using ethyl acetate : methanol : ammonia 33% (10 : 1 : 0.1 v/v/v) as the mobile phase. The Rf values were 0.74, 0.50, 0.30+/-0.01 for DRT, NIF and 4-HBH, respectively. On the fluorescent plates, the spots were located by fluorescence quenching and the densitometrical area were measured at 308 and 287 nm with linear range 0.2-4 mug/spot and 0.6-12 mug/spot for DRT and NIF, respectively. The proposed methods have been successfully applied to the commercial pharmaceutical formulation without any interference of excipients. Mean recoveries, relative standard deviations and the results of the proposed methods were compared with those obtained by applying the alternate methods.     

LC–MS Simultaneous Determination of Itopride Hydrochloride and Domperidone in Human Plasma

A rapid, simple, sensitive and specific liquid chromatography–tandem mass spectrometry method was developed and validated for simultaneous quantification of itopride hydrochloride and domperidone in human plasma. Both drugs were extracted by liquid–liquid extraction with ethyl acetate and saturated borax solution. The chromatographic separation was performed on a reversed-phase C18 column with a mobile phase of water–methanol (2:98, v/v) containing 0.5% formic acid. The protonated analyte was quantitated in positive ionization by multiple reaction monitoring with a mass spectrometer. The assay exhibited linearity over the concentration range of 3.33–500 ng mL⁻¹ for itopride hydrochloride and 3.33–100 ng mL⁻¹ for domperidone in human plasma. The precursor to product ion transitions of m/z 359.1–72.3 and 426.0–147.2 were used to measure itopride hydrochloride and domperidone respectively. The method was found suitable for the analysis of plasma samples collected during phase 1 pharmacokinetics study of itopride HCl 50 mg and domperidone 20 mg in 12 healthy volunteers after single oral doses of the combination drug.

     

LC–MS Simultaneous Determination of Itopride Hydrochloride and Domperidone in Human Plasma

A rapid, simple, sensitive and specific liquid chromatography–tandem mass spectrometry method was developed and validated for simultaneous quantification of itopride hydrochloride and domperidone in human plasma. Both drugs were extracted by liquid–liquid extraction with ethyl acetate and saturated borax solution. The chromatographic separation was performed on a reversed-phase C18 column with a mobile phase of water–methanol (2:98, v/v) containing 0.5% formic acid. The protonated analyte was quantitated in positive ionization by multiple reaction monitoring with a mass spectrometer. The assay exhibited linearity over the concentration range of 3.33–500 ng mL^?1 for itopride hydrochloride and 3.33–100 ng mL^?1 for domperidone in human plasma. The precursor to product ion transitions of m/z 359.1–72.3 and 426.0–147.2 were used to measure itopride hydrochloride and domperidone respectively. The method was found suitable for the analysis of plasma samples collected during phase 1 pharmacokinetics study of itopride HCl 50 mg and domperidone 20 mg in 12 healthy volunteers after single oral doses of the combination drug.     

Spectrophotometric Methods for the Determination of Acediasulfone in Mixture with Cinchocaine

Abstract

Derivative spectrophotometry techniques (ratio‐spectra first derivative and zero‐crossing first derivative) were described for simultaneous determination of acediasulfone and cinchocaine. Acediasulfone was also determined via the formation of a colored product as a result of its reaction with p‐dimethylaminobenzaldehyde. In the ratio‐spectra first derivative method, the measurements were taken at 310 and 233.9 nm for acediasulfone and cinchocaine, respectively. By the zero‐crossing first derivative method, lines of regression were taken at 318 and 233 nm for acediasulfone and cinchocaine, respectively. In the colorimetric method, absorbance measurements were obtained at 452 nm. Acediasulfone showed linearity over concentration ranges 2–14 µg/ml, 2–16 µg/ml, and 12–60 µg/ml for ratio‐spectra first derivative, zero‐crossing first derivative, and colorimetric methods, whereas cinchocaine showed linearity over concentration ranges 1–10 µg/ml and 2.28–16 µg/ml for ratio‐spectra first derivative and zero‐crossing first derivative techniques. The proposed methods proved to be specific and accurate for the analysis of the cited drugs in laboratory‐prepared mixtures and dosage form. The obtained results agree statistically with those obtained by reference methods.     

Spectrophotometric and spectrodensitometric determination of paracetamol and drotaverine HCl in combination

Thin-layer chromatography, first derivative, ratio spectra derivative spectrophotometry and Vierordt's method have been developed for the simultaneous determination of paracetamol and drotaverine HCl. TLC densitometric method depends on the difference in Rf values using ethyl acetate:methanol:ammonia (100:1:5 v/v/v) as a mobile phase. The spots of the two drugs were scanned at 249 and 308 nm over concentration ranges of 60-1200 microg/ml and 20-400 microg/ml with mean percentage recovery 100.11%+/-1.91 and 100.15%+/-1.87, respectively. The first derivative spectrophotometric method deals with the measurements at zero-crossing points 259 and 325 nm with mean percentage recovery 99.25%+/-1.08 and 99.45%+/-1.14, respectively. The ratio spectra first derivative technique was used at 246 and 305 nm with mean percentage recovery 99.75%+/-1.93 and 99.08%+/-1.22, respectively. Beer's law for first derivative and ratio spectra derivative methods was obeyed in the concentration range 0.8-12.8 and 0.4-6.4 microg/ml of paracetamol and drotaverine HCl, respectively. Vierordt's method was applied to over come the overlapping of paracetamol and drotaverine HCl in zero-order spectra in concentration range 2-26 and 2-40 microg/ml respectively. The suggested methods were successfully applied for the analysis of the two drugs in laboratory prepared mixtures and their pharmaceutical formulation. The validity of the methods was assessed by applying the standard addition technique. The obtained results were statistically agreed with those obtained by the reported method.     

A new spectrophotometric method for quantitative multicomponent analysis resolution of mixtures of salicylic and salicyluric acids

A new spectrophotometric method for resolving binary mixtures is proposed. The method is based on use of the first derivative of the ratios of spectra. The absorption spectrum of the mixture is obtained and the amplitudes at appropriate wavelengths are divided by the corresponding amplitudes in the absorption spectrum of a standard solution of one of the components, and the first derivative of the ratio spectrum is obtained. The concentration of the other component is then determined from a calibration graph. The method has been applied for resolving binary mixtures of salicylic and salicyluric acids. Calibration graphs for 2.6-52 ppm salicylic acid and for 2.1-42 ppm salicyluric acid were established by measuring the analytical signals at the maximum at 241.5 nm (for salicylic acid) and from the peak at 258 nm to the trough at 247 nm (for salicyluric acid) in the first derivative ratio spectra.     

Derivative spectrophotometric analysis of benzophenone (as an impurity) in phenytoin

ABSTRACT: Three simple and rapid spectrophotometric methods were developed for detection and trace determination of benzophenone (the main impurity) in phenytoin bulk powder and pharmaceutical formulations. The first method, zero-crossing first derivative spectrophotometry, depends on measuring the first derivative trough values at 257.6 nm for benzophenone. The second method, zero-crossing third derivative spectrophotometry, depends on measuring the third derivative peak values at 263.2 nm. The third method, ratio first derivative spectrophotometry, depends on measuring the peak amplitudes of the first derivative of the ratio spectra (the spectra of benzophenone divided by the spectrum of 5.0 μg/mL phenytoin solution) at 272 nm. The calibration graphs were linear over the range of 1-10 μg/mL. The detection limits of the first and the third derivative methods were found to be 0.04 μg/mL and 0.11 μg/mL and the quantitation limits were 0.13 μg/mL and 0.34 μg/mL, respectively, while for the ratio derivative method, the detection limit was 0.06 μg/mL and the quantitation limit was 0.18 μg/mL. The proposed methods were applied successfully to the assay of the studied drug in phenytoin bulk powder and certain pharmaceutical preparations. The results were statistically compared to those obtained using a polarographic method and were found to be in good agreement.     

HPLC and chemometrics-assisted UV-spectroscopy methods for the simultaneous determination of ambroxol and doxycycline in capsule

High-performance liquid chromatography (HPLC) and multivariate spectrophotometric methods are described for the simultaneous determination of ambroxol hydrochloride (AM) and doxycycline (DX) in combined pharmaceutical capsules. The chromatographic separation was achieved on reversed-phase C(18) analytical column with a mobile phase consisting of a mixture of 20mM potassium dihydrogen phosphate, pH 6-acetonitrile in ratio of (1:1, v/v) and UV detection at 245 nm. Also, the resolution has been accomplished by using numerical spectrophotometric methods as classical least squares (CLS), principal component regression (PCR) and partial least squares (PLS-1) applied to the UV spectra of the mixture and graphical spectrophotometric method as first derivative of the ratio spectra ((1)DD) method. Analytical figures of merit (FOM), such as sensitivity, selectivity, analytical sensitivity, limit of quantitation and limit of detection were determined for CLS, PLS-1 and PCR methods. The proposed methods were validated and successfully applied for the analysis of pharmaceutical formulation and laboratory-prepared mixtures containing the two component combination.     

Simultaneous determination and validation of some binary mixtures of antihypertensive drugs using ratio derivative spectrophotometric method

Ratio derivative spectrophotometric technique is presented for the rapid, accurate and precise simultaneous determination of olmesartan medoxomil (OLM), hydrochlorothiazide (HCT), and zofenopril (ZOF) as well as HCT binary mixtures in their dosage forms. First derivative of the ratio spectra (DD1) by measurements using different amplitudes was used and calibration graphs were established for 0.5–12 mg/mL HCT and 0.5–20 mg/mL OLM and ZOF. This method depends on first derivative of the ratio spectra by division of the absorption spectrum of the binary mixture by a standard spectrum of one of the components and then calculating the first derivative of the ratio spectrum. The first derivative of the ratio amplitudes at 250.4 and 291.5 nm for OLM, 250.4 and 298.1 nm for ZOF and 231.8, 332.2, 232.3 and 280.4 nm for HCT were selected for the determination. The proposed methods were successfully applied for determining of both drug combinations (ZOF-HCT and OLM-HCT) in their synthetic mixtures and in pharmaceutical dosage forms. The described procedures are extensively validated, non-destructive and do not require any separation steps.     

Spectrophotometric determination of phenothiazines, tetracyclines and chloramphenicol with sodium cobaltinitrite

A spectrophotometric method for determining some phenothiazines, some tetracyclines and chloramphenicol is described. Chlorpromazine hydrochloride, promazine hydrochloride, promethazine hydrochloride, perphenazine and fluphenazine hydrochloride are reacted with sodium cobaltinitrite in phosphoric acid. The red colour developed is measured at 530, 513, 515, 530 and 500 nm, respectively. Tetracycline hydrochloride, oxytetracycline hydrochloride, chlortetracycline hydrochloride, doxycycline hyclate and demeclocycline hydrochloride are reacted with the reagent in aqueous acetic acid. The yellow colour produced is measured at 256, 294, 262, 243 and 246 nm, respectively. Chloramphenicol is determined similarly to the tetracyclines after hydrolysis with 40% sodium hydroxide solution and the colour is measured at 240 nm. The proposed method has been successfully applied to the determination of these drugs in various pharmaceutical preparations.     

Simultaneous Determination of Levomepromazine Hydrochloride and Its Sulfoxide by UV‐Derivative Spectrophotometry and Bivariate Calibration Method

Abstract

Two spectrophotometric methods are proposed for the simultaneous quantification of levomepromazine hydrochloride (LV) and its main degradation product levomepromazine sulfoxide (LV‐SO). One of them is based on the first order derivative spectra generated by the Savitzky‐Golay algorithm (third‐order polynomial degree, Δλ=10 nm). Determination of levomepromazine hydrochloride and its sulfoxide was realized by measurements of amplitudes of derivative spectra at 332 nm and 278 nm, respectively. The Beer law was obeyed in the concentration range 1.5–50 µg/mL for LV and 2.5–50 µg/mL for LV‐SO. The second of the proposed methods utilized the bivariate calibration algorithm. The determination was performed at 302 nm for levomepromazine and at 334 nm for sulfoxide. The elaborated methods allowed determination of LV in the concentration range 1.0–25 µg/mL while LV‐SO was determined in the concentration range 2.0–50 µg/mL.